Amidst a growing counterculture sparked by the Vietnam War and the US civil rights movement, bariatric surgery as we know it today had its beginnings in 1965 in a research laboratory at the University of Iowa. Today, as obesity reaches epidemic proportions, bariatric surgery has established its place as the most effective treatment for achieving substantial weight loss and improving or even resolving comorbid conditions such as diabetes, hypertension, and sleep apnea, especially in the morbidly obese.
DeNovo Ventures’ Managing Director Joe Mandato speaks with minimally invasive surgery/robotics pioneer Fred Moll, MD. Moll founded three public robotics companies, co-founded Origin MedSystems and Gynecare, and recently raised a record amount of capital for a new device company, Auris Health. Moll is an innovator, entrepreneur, and seasoned board member, and he speaks with Mandato about board governance.
“Briteseed’s Burgeoning Smart Surgical Tools Stop Unsafe Bleeding.” Chicago-based Briteseed LLC is developing the next generation of smart surgical tools that can provide visual, anatomical information to surgeons in real-time. In addition to improving patient outcomes, Jonathan believes Briteseed could offer significant cost savings for payors and providers impacted by non-reimbursable costs. In this interview, CEO Jonathan Gunn, Phd, JD, talks about his early inspiration and his experiences in co-founding the company, his current priorities, and what’s next for Briteseed.
“Conavi: Completing the Picture for Intravascular Imaging.” Toronto-based commercial-stage medical device company Conavi Medical is developing image guidance technologies for use in minimally invasive cardiovascular procedures and is on a mission “to make procedures that are established or emerging safer, faster, and with better outcomes.” In this interview, Brian talks about his inspiration and early experiences in founding the company, his current priorities, and what’s next for Conavi.
“From Railroads to Robots: The Story Behind Deneb Medical.” Spain-based start-up Deneb Medical is developing a surgical robot for selective tissue ablation called CoBot, which the Co-founders believe will directly reduce the risk of unintended damage to critical anatomical structures. In this candid interview, the Co-founders talk about their inspiration and early experiences in founding the company, their current priorities, and what’s next.
In this week’s post, we continue our look at executives working to make an impact in surgical robotics, including David McNally, CEO of Titan Medical, and Christopher Prentice, CCO at Mazor Robotics. Also, we note a few observations from last week’s annual Society of Robotic Surgery (SRS) conference in Stockholm, where key executives from all the major robotics companies assembled to discuss the current status and future of the field. [Read Part 1]
Back in 1990, the same year that Americans were paying on average $1.34 for a gallon of gas, Space Shuttle Discovery placed the Hubble Space Telescope into orbit, and Tim Berners-Lee of Switzerland published his formal proposal for a concept called the “World Wide Web,” the surgical robotics revolution was born. [Read Part 2]